Company / Operating Cash Flow per Share
Solid Biosciences Inc. Operating Cash Flow per Share History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$7.69
FY2022
5-year range
-$7.69 / -$1.09
FY2019-FY2022
Trend
-604.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -605% YoY in FY2022, a notable deviation from the 3-year average annual change of -200%.
Based on SEC 10-K filings.
-7.69 in FY2022.
Declined from $-1.53 to $-7.69 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow per share decreased 604.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$7.69 | -604.5% |
| FY2021 | -$1.09 | +28.5% |
| FY2020 | -$1.53 | -25.1% |
| FY2019 | -$1.22 | - |
| FY2018 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026